Factors associated with blood culture positivity in patients with complicated skin and skin structure infection-a population-based study
- PMID: 31011854
- PMCID: PMC6570775
- DOI: 10.1007/s10096-019-03560-9
Factors associated with blood culture positivity in patients with complicated skin and skin structure infection-a population-based study
Abstract
Skin and skin structure infection (SSSI) is classified as complicated (cSSSI) if it involves deep subcutaneous tissue or requires surgery. Factors associated with blood culture sampling and bacteremia have not been established in patients with cSSSI. Moreover, the benefit of information acquired from positive blood culture is unknown. The aim of this study was to address these important issues. In this retrospective population-based study from two Nordic cities, a total of 460 patients with cSSSI were included. Blood cultures were drawn from 258 (56.1%) patients and they were positive in 61 (23.6%) of them. Factors found to be associated with more blood culture sampling in multivariate analysis were diabetes, duration of symptoms shorter than 2 days and higher C-reactive protein (CRP) level. Whereas factors associated with less frequent blood culture sampling were peripheral vascular disease and a surgical wound infection. In patients from whom blood cultures were taken, alcohol abuse was the only factor associated with culture positivity, as CRP level was not. Patients with a positive blood culture had antibiotic streamlining more often than non-bacteremic patients. A high rate of blood culture positivity in patients with cSSSI was observed. Factors related to more frequent blood culture sampling were different from those associated with a positive culture.
Keywords: Abscess; Bacteremia; Bloodstream infection; C-reactive protein; Cellulitis; Skin and soft tissue infection.
Conflict of interest statement
MH has received a lecture fee from OrionPharma, Ratiopharm and MSD; a conference invitation from Gilead; and has recent consultancies with Pfizer. IHJ has received a conference invitation from Gilead. AJ has received speaker’s honoraria from Astellas, Cardiome, MSD, OrionPharma, Pfizer, Ratiopharm and Unimedic; and congress support from MSD and Steripolar.
References
-
- Center for Drug Evaluation and Research, Food and Drug Administration (1998) Guidance for industry: uncomplicated and complicated skin and skin structure infections - developing antimicrobial drugs for treatment. Washington, DC: Food and Drug Administration, US Department of Health and Human Services
-
- Dryden MS. Complicated skin and soft tissue infection. J Antimicrob Chemother. 2010;65(Suppl 3):iii35–iii44. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials